These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2607778

  • 1. Prognostic implication of sequential bone marrow cultures in the myelodysplastic syndromes.
    Yoshida Y, Yoshida C, Tohyama K, Ohmori S, Ohmori M, Ueda Y, Taniguchi Y, Uchino H.
    Leuk Res; 1989; 13(11):967-72. PubMed ID: 2607778
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
    Shih LY, Chiu WF, Lee CT.
    Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
    Gronda M, Malka A, Demattei A, Elizalde P, Santarelli MT, Bianchi de Di Risio CC.
    Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bone marrow cultures and prognosis in primary myelodysplastic syndromes.
    Korthout M, De Bock R, van Bockstaele D, Peetermans M.
    Leuk Res; 1990 Aug; 14(1):85-9. PubMed ID: 2304356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 14. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
    Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki I, Shinohara T.
    Acta Haematol; 1993 Aug; 89(3):113-8. PubMed ID: 8362599
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S, Wagemaker G, Souza LM, Tatarsky I.
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
    Oscier DG, Worsley A, Darlow S, Figes A, Williams JD, Hamblin TJ.
    Leuk Res; 1989 Apr; 13(9):833-9. PubMed ID: 2796388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.